Stroke gets the most study time in most CPTE preparation plans. It deserves it — cerebrovascular disease is high-frequency on both the Written and Oral sections. But neurology is a 20–25% domain, and in any given exam there will be multiple questions on Parkinson's Disease, Multiple Sclerosis, and Spinal Cord Injury — conditions where the management principles are distinct enough that guessing from stroke knowledge often gives the wrong answer.
This guide targets those three conditions specifically, with the clinical reasoning patterns that earn marks on the CPTE. Clinical standards referenced come from Parkinson Canada, MS Society of Canada, and Spinal Cord Injury Canada.
Parkinson's Disease — where assessment and progression are inseparable
Parkinson's Disease (PD) is a progressive neurodegenerative condition caused by dopaminergic neuron loss in the substantia nigra. The cardinal motor features are bradykinesia, rigidity, resting tremor, and postural instability. Non-motor features — depression, cognitive change, sleep disturbance, constipation, autonomic dysfunction — are clinically significant and appear in CPTE cases.
Staging: The Hoehn & Yahr (H&Y) Scale classifies PD from Stage I (unilateral) through Stage V (wheelchair or bed-bound). The MDS-UPDRS (Movement Disorder Society–Unified Parkinson's Disease Rating Scale) is a comprehensive assessment used in research and clinical settings. The CPTE expects you to recognize H&Y staging and know what functional limitations correspond to each level.
Key physiotherapy principles:
- LSVT BIG (Lee Silverman Voice Treatment — BIG) is a high-intensity, amplitude-focused upper limb and gait training program with Level 1 evidence for PD. It targets bradykinesia by training high-amplitude movements explicitly
- Cueing strategies (auditory rhythm, visual lines on the floor, tactile) reduce freezing of gait and improve stride length — cue externally when internal movement initiation fails
- Treadmill training and dance programs have emerging evidence for gait improvement in PD
- Exercise is neuroprotective — higher intensity exercise (where tolerated) is associated with slower functional decline in PD research
The medication-therapy interaction: PD patients typically take levodopa-carbidopa, and their motor function fluctuates with medication timing. "ON" states (medication working) allow higher exercise intensity and more complex movement practice. "OFF" states produce the most pronounced symptoms. Schedule demanding PT sessions during the ON phase, typically 60–90 minutes after medication. Knowing this is a CPTE-tested clinical reasoning point.
When to urgently refer: A physiotherapist treating a PD patient notices significantly increased freezing, new hypophonia, or a fall history. These are signs of disease progression that may warrant medication review by the neurologist or GP. The Collaborator role expects you to communicate this proactively — not wait for the next scheduled appointment.
Outcome measures for PD:
- Timed Up and Go (TUG) — mobility and fall risk
- Berg Balance Scale (BBS) — balance
- 10 Metre Walk Test — gait speed
- PDQ-39 — Parkinson's-specific quality of life questionnaire
Multiple Sclerosis — the relapsing-remitting pattern and fatigue management
Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS. The most common form, relapsing-remitting MS (RRMS), involves episodic exacerbations (relapses) followed by partial or full recovery. Progressive forms (PPMS, SPMS) involve steady decline without clear relapses.
What makes MS physiotherapy different from other neuro conditions:
- Heat sensitivity (Uhthoff's phenomenon): In many people with MS, elevated body temperature — from exercise, hot weather, or a hot shower — temporarily worsens neurological symptoms. This is Uhthoff's phenomenon. It resolves when core temperature returns to normal and is not a relapse. However, it means PT sessions should be scheduled in cooler environments, and cooling strategies (cool towels, cool drinks, air conditioning) are used during exercise
- Fatigue is a cardinal symptom: MS fatigue is neurological, not just deconditioning. Energy management and pacing are core physiotherapy interventions. The Modified Fatigue Impact Scale (MFIS) measures MS-specific fatigue across physical, cognitive, and psychosocial dimensions
- Relapse precaution: Do not apply progressive exercise loads during an active MS relapse. During a relapse, the focus shifts to maintaining existing function and preventing secondary complications while disease-modifying therapy takes effect
Outcome measures for MS:
- Expanded Disability Status Scale (EDSS) — neurological disability staging (0–10)
- Multiple Sclerosis Impact Scale (MSIS-29) — patient-reported impact
- 6-Minute Walk Test (6MWT) — walking endurance
- Berg Balance Scale — balance
- Modified Fatigue Impact Scale (MFIS) — fatigue
Exercise and MS: Despite historical concerns, exercise is now firmly evidence-supported for MS. Systematic reviews demonstrate improvements in fatigue, depression, mobility, and quality of life. The key is: avoid heat accumulation, respect the patient's energy envelope, and distinguish MS fatigue from exercise-appropriate exertion.
Spinal Cord Injury — the classification system that governs everything
Spinal Cord Injury (SCI) requires a working knowledge of the ASIA Impairment Scale (AIS) — the classification system that determines what deficits to expect, what goals are achievable, and what precautions apply.
ASIA Impairment Scale:
- AIS A — Complete: no motor or sensory function preserved at S4–S5
- AIS B — Incomplete: sensory but not motor function preserved below the neurological level
- AIS C — Incomplete: motor function preserved below the neurological level; >half of key muscles below grade 3
- AIS D — Incomplete: motor function preserved below the neurological level; at least half of key muscles grade 3 or above
- AIS E — Normal sensorimotor function (used when there was previously abnormal, now recovered)
Functional expectations by level: The CPTE expects you to know what functional independence is realistic for different injury levels. Key landmarks:
- C4 and above — Dependent for all mobility and self-care; requires power wheelchair
- C5–C6 — Can operate power wheelchair; some upper limb function; may achieve independence with feeding and grooming with equipment
- C7 — Can perform many transfers independently; manual wheelchair on level surfaces; more upper limb function
- T1–T6 — Full upper limb function; manual wheelchair; SCI above T6 carries risk of autonomic dysreflexia
- T10–L1 — Potential for limited household ambulation with orthotics
- L2 and below — Community ambulation potential with or without orthotics; bladder and bowel management often the primary focus
Autonomic dysreflexia (AD) — the emergency physiotherapists must recognize: AD is a medical emergency in SCI at or above T6. It presents as a sudden, severe headache, hypertension (systolic >20 mmHg above baseline), diaphoresis above the lesion, and bradycardia. The cause is a noxious stimulus below the injury (most commonly bladder distension from a kinked catheter or a full bladder). First response: sit the patient upright, remove the noxious stimulus, monitor blood pressure. If unresolved, call for medical assistance. Do not confuse with a relapse or stroke.
Neurogenic bowel and bladder: Most SCI cases will have neurogenic bowel and bladder as a component of the picture. Physiotherapists are not the primary manager of these but must understand the implications for exercise timing, positioning, and patient dignity during sessions.
Pressure injury prevention: Regular repositioning, appropriate wheelchair cushions, and skin inspection are part of the physiotherapist's scope in SCI management. Pressure injuries over bony prominences (ischial tuberosities, sacrum, heels) are a leading cause of SCI-related hospitalizations.
The 2026 CPTE and the CanMEDS-PT roles in neuro cases
The 2026 CPTE Written and Oral sections embed professional competencies into clinical cases. In neurology cases specifically, watch for:
- Communicator role: How do you communicate a poor prognosis (e.g., AIS A at C4) with empathy and accuracy? How do you explain exercise progression to a cognitively impaired PD patient?
- Collaborator role: When do you refer a PD patient's declining function back to neurology? What is your role in the interprofessional SCI team?
- Health Advocate role: How do you address barriers to community reintegration for an MS patient with fatigue limiting their ability to attend outpatient sessions?
- Scholar role: What is the evidence for LSVT BIG vs general exercise in PD? How do you apply the GRADE framework to a question about MS exercise?
The correct answer in Oral station neuro cases is almost never purely clinical. It integrates clinical reasoning with one or more of these roles — usually the Communicator and Collaborator.
At PhysioExamPrep, the Neurological chapter covers PD, MS, SCI, stroke, and related conditions with scenario-based questions, ASIA classification practice, and Oral section case templates. The mock exam is weighted to the 2026 CPTE blueprint.
Sources: Parkinson Canada clinical practice guidelines; MS Society of Canada; Spinal Cord Injury Canada; ASIA/ISCoS International Standards for Neurological Classification of SCI.